FDA’s new mammography proposal to help enhance diagnosis accuracy
Category: #health  By Mateen Dalal  Date: 2019-03-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

FDA’s new mammography proposal to help enhance diagnosis accuracy

The FDA (Food & Drug Administration) has reportedly proposed a new rule that would require mammography providers to inform female patients with dense breast tissue about the fact that the condition may impact the accuracy of their mammograms. The proposed regulation, apparently, will help women ponder over whether they need to consult their doctors regarding additional tests for checking on breast cancer.

The issue has turned out to be immensely critical in the wake of recent findings highlighting that dense breast tissue is a major cause behind the incline in the chances of breast cancer development. Sources with the knowledge of the matter revealed that the growth of the dense breast tissue makes it quite difficult to discover malignancies on the mammograms. Reports state that around three dozen states already have several laws concerning breast density notifications, however, FDA’s latest proposal aims to establish a standard that is applicable throughout the nation. 

The proposal is expected to upgrade the regulations mentioned under the Mammography Quality Standards Act, 1992, which helped bring around 8,000 mammography facilities in the United States under federal supervision. The rules, for the record, involve annual inspections, authorization of the facilities and enforcement of effective mammography rules.

According to The Washington Post, the NCI (National Cancer Institute) has reported that dense breasts contain rather high amounts of fibrous connective tissue and glandular tissue, while having low amount of fatty tissue. Nowadays, women at the age of 40 and older get diagnosed with dense breasts through their mammograms, and since such tissue seems white on the mammogram, resembling cancer, it tends to cover the malignancies. However, the dense breasts enhance the risk of developing breast cancer, confirmed the NCI.

Reportedly, the latest proposal is likely to incorporate advances including 3-D digital screening tools, into mammography services. It would help the agency notify patients, along with their healthcare providers, if a mammography provider fails to meet the quality standard and the need for a repeat test arises.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Deciphera to present data from DCC-3014 trial at CTOS annual meet
Deciphera to present data from DCC-3014 trial at CTOS annual meet
By Mateen Dalal

The ongoing clinical trial of DCC-3014 have shown preliminary anti-tumor activity.    DCC-3014 validates emerging tolerability profile with no Grade 3 or Higher TEAEs.   Encore presentation of data from the INVICTUS Pivotal Phase...

Roches risdiplam meets primary endpoint results in phase 3 trial
Roches risdiplam meets primary endpoint results in phase 3 trial
By Mateen Dalal

Spinal muscular atrophy (SMA) is a genetic neuromuscular condition, affecting approx. 1 in 6,000 babies born globally each year. Numerous healthcare companies throughout the world are putting their best foot forward to develop an effective ...

Disney+ all set for a March 2020 launch in the United Kingdom
Disney+ all set for a March 2020 launch in the United Kingdom
By Mateen Dalal

The entertainment behemoth is launching its much-awaited streaming platform.   Release of more than 300 movies is on the cards. Disney has finally asserted that new streaming service Disney+ will be rolled out soon in the U.K. Disney+ goes...